Ocular Toxicity Related to Cetuximab Monotherapy in an Advanced Colorectal Cancer Patient
include acneiform eruptions, seborr heic der matitis-like eruptions, and maculopapular CORRESPONDENCE CORRESPONDENCE Fig. 1. Clinical spectrum of the ocular side effects related to cetuximab monotherapy. ( A , B ) Details of the lower lid margin of a patient treated with cetuximab,
Gespeichert in:
| Veröffentlicht in: | JNCI : Journal of the National Cancer Institute 2005-04, Vol.97 (8), p.606-607 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 607 |
|---|---|
| container_issue | 8 |
| container_start_page | 606 |
| container_title | JNCI : Journal of the National Cancer Institute |
| container_volume | 97 |
| creator | Tonini, Giuseppe Vincenzi, Bruno Santini, Daniele Olzi, Diego Lambiase, Alessandro Bonini, Stefano |
| description | include acneiform eruptions, seborr heic der matitis-like eruptions, and maculopapular CORRESPONDENCE CORRESPONDENCE Fig. 1. Clinical spectrum of the ocular side effects related to cetuximab monotherapy. ( A , B ) Details of the lower lid margin of a patient treated with cetuximab, |
| doi_str_mv | 10.1093/jnci/dji104 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17574940</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>862837311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-496f45a0185c72101e531a28a85d4d683ad94daf5ee907fef66e445483c1b95d3</originalsourceid><addsrcrecordid>eNpdkNFLHDEQh4O01NP2qe8l9MEX2Zpskt3kURZbFVuLWFBfQi6Zpbnubc4kK3f_vTnuaKHzMjDzMfPjQ-gjJV8oUexsMVp_5haeEn6AZpQ3pKopEW_QjJC6raRs-SE6SmlBSqmav0OHVEhOpOQz9Hhrp8FEfB_W3vq8wXcwmAwO54A7yNPaL80cfw9jyL8hmtUG-xGbEZ-7FzPawnVhCBFsNgPutpOIf5rsYczv0dveDAk-7Psx-vX14r67rG5uv1115zeVZVLliqum58IQKoVtS24KglFTSyOF466RzDjFnekFgCJtD33TAOeCS2bpXAnHjtHJ7u4qhucJUtZLnywMgxkhTEnTVrRccVLAz_-BizDFsWTTdXlci5qpAp3uIBtDShF6vYpFQdxoSvRWt97q1jvdhf60PznNl-D-sXu_Bah2gE8Z1n_3Jv7RTctaoS8fnjR9uLumTfekf7BXg5mKtA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221025239</pqid></control><display><type>article</type><title>Ocular Toxicity Related to Cetuximab Monotherapy in an Advanced Colorectal Cancer Patient</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Tonini, Giuseppe ; Vincenzi, Bruno ; Santini, Daniele ; Olzi, Diego ; Lambiase, Alessandro ; Bonini, Stefano</creator><creatorcontrib>Tonini, Giuseppe ; Vincenzi, Bruno ; Santini, Daniele ; Olzi, Diego ; Lambiase, Alessandro ; Bonini, Stefano</creatorcontrib><description>include acneiform eruptions, seborr heic der matitis-like eruptions, and maculopapular CORRESPONDENCE CORRESPONDENCE Fig. 1. Clinical spectrum of the ocular side effects related to cetuximab monotherapy. ( A , B ) Details of the lower lid margin of a patient treated with cetuximab,</description><identifier>ISSN: 0027-8874</identifier><identifier>EISSN: 1460-2105</identifier><identifier>DOI: 10.1093/jnci/dji104</identifier><identifier>PMID: 15840884</identifier><identifier>CODEN: JNCIEQ</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Adenocarcinoma - drug therapy ; Antibodies, Monoclonal - administration & dosage ; Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - adverse effects ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Blepharitis - chemically induced ; Blepharitis - pathology ; Cetuximab ; Colorectal cancer ; Colorectal Neoplasms - drug therapy ; Female ; Humans ; Middle Aged ; Receptor, Epidermal Growth Factor - antagonists & inhibitors</subject><ispartof>JNCI : Journal of the National Cancer Institute, 2005-04, Vol.97 (8), p.606-607</ispartof><rights>Copyright Oxford University Press(England) Apr 20, 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-496f45a0185c72101e531a28a85d4d683ad94daf5ee907fef66e445483c1b95d3</citedby><cites>FETCH-LOGICAL-c389t-496f45a0185c72101e531a28a85d4d683ad94daf5ee907fef66e445483c1b95d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15840884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tonini, Giuseppe</creatorcontrib><creatorcontrib>Vincenzi, Bruno</creatorcontrib><creatorcontrib>Santini, Daniele</creatorcontrib><creatorcontrib>Olzi, Diego</creatorcontrib><creatorcontrib>Lambiase, Alessandro</creatorcontrib><creatorcontrib>Bonini, Stefano</creatorcontrib><title>Ocular Toxicity Related to Cetuximab Monotherapy in an Advanced Colorectal Cancer Patient</title><title>JNCI : Journal of the National Cancer Institute</title><addtitle>JNCI J Natl Cancer Inst</addtitle><description>include acneiform eruptions, seborr heic der matitis-like eruptions, and maculopapular CORRESPONDENCE CORRESPONDENCE Fig. 1. Clinical spectrum of the ocular side effects related to cetuximab monotherapy. ( A , B ) Details of the lower lid margin of a patient treated with cetuximab,</description><subject>Adenocarcinoma - drug therapy</subject><subject>Antibodies, Monoclonal - administration & dosage</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Blepharitis - chemically induced</subject><subject>Blepharitis - pathology</subject><subject>Cetuximab</subject><subject>Colorectal cancer</subject><subject>Colorectal Neoplasms - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Receptor, Epidermal Growth Factor - antagonists & inhibitors</subject><issn>0027-8874</issn><issn>1460-2105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkNFLHDEQh4O01NP2qe8l9MEX2Zpskt3kURZbFVuLWFBfQi6Zpbnubc4kK3f_vTnuaKHzMjDzMfPjQ-gjJV8oUexsMVp_5haeEn6AZpQ3pKopEW_QjJC6raRs-SE6SmlBSqmav0OHVEhOpOQz9Hhrp8FEfB_W3vq8wXcwmAwO54A7yNPaL80cfw9jyL8hmtUG-xGbEZ-7FzPawnVhCBFsNgPutpOIf5rsYczv0dveDAk-7Psx-vX14r67rG5uv1115zeVZVLliqum58IQKoVtS24KglFTSyOF466RzDjFnekFgCJtD33TAOeCS2bpXAnHjtHJ7u4qhucJUtZLnywMgxkhTEnTVrRccVLAz_-BizDFsWTTdXlci5qpAp3uIBtDShF6vYpFQdxoSvRWt97q1jvdhf60PznNl-D-sXu_Bah2gE8Z1n_3Jv7RTctaoS8fnjR9uLumTfekf7BXg5mKtA</recordid><startdate>20050420</startdate><enddate>20050420</enddate><creator>Tonini, Giuseppe</creator><creator>Vincenzi, Bruno</creator><creator>Santini, Daniele</creator><creator>Olzi, Diego</creator><creator>Lambiase, Alessandro</creator><creator>Bonini, Stefano</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7T2</scope><scope>7U2</scope></search><sort><creationdate>20050420</creationdate><title>Ocular Toxicity Related to Cetuximab Monotherapy in an Advanced Colorectal Cancer Patient</title><author>Tonini, Giuseppe ; Vincenzi, Bruno ; Santini, Daniele ; Olzi, Diego ; Lambiase, Alessandro ; Bonini, Stefano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-496f45a0185c72101e531a28a85d4d683ad94daf5ee907fef66e445483c1b95d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adenocarcinoma - drug therapy</topic><topic>Antibodies, Monoclonal - administration & dosage</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Blepharitis - chemically induced</topic><topic>Blepharitis - pathology</topic><topic>Cetuximab</topic><topic>Colorectal cancer</topic><topic>Colorectal Neoplasms - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Receptor, Epidermal Growth Factor - antagonists & inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tonini, Giuseppe</creatorcontrib><creatorcontrib>Vincenzi, Bruno</creatorcontrib><creatorcontrib>Santini, Daniele</creatorcontrib><creatorcontrib>Olzi, Diego</creatorcontrib><creatorcontrib>Lambiase, Alessandro</creatorcontrib><creatorcontrib>Bonini, Stefano</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><jtitle>JNCI : Journal of the National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tonini, Giuseppe</au><au>Vincenzi, Bruno</au><au>Santini, Daniele</au><au>Olzi, Diego</au><au>Lambiase, Alessandro</au><au>Bonini, Stefano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ocular Toxicity Related to Cetuximab Monotherapy in an Advanced Colorectal Cancer Patient</atitle><jtitle>JNCI : Journal of the National Cancer Institute</jtitle><addtitle>JNCI J Natl Cancer Inst</addtitle><date>2005-04-20</date><risdate>2005</risdate><volume>97</volume><issue>8</issue><spage>606</spage><epage>607</epage><pages>606-607</pages><issn>0027-8874</issn><eissn>1460-2105</eissn><coden>JNCIEQ</coden><abstract>include acneiform eruptions, seborr heic der matitis-like eruptions, and maculopapular CORRESPONDENCE CORRESPONDENCE Fig. 1. Clinical spectrum of the ocular side effects related to cetuximab monotherapy. ( A , B ) Details of the lower lid margin of a patient treated with cetuximab,</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>15840884</pmid><doi>10.1093/jnci/dji104</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0027-8874 |
| ispartof | JNCI : Journal of the National Cancer Institute, 2005-04, Vol.97 (8), p.606-607 |
| issn | 0027-8874 1460-2105 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_17574940 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Adenocarcinoma - drug therapy Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal, Humanized Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Blepharitis - chemically induced Blepharitis - pathology Cetuximab Colorectal cancer Colorectal Neoplasms - drug therapy Female Humans Middle Aged Receptor, Epidermal Growth Factor - antagonists & inhibitors |
| title | Ocular Toxicity Related to Cetuximab Monotherapy in an Advanced Colorectal Cancer Patient |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A17%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ocular%20Toxicity%20Related%20to%20Cetuximab%20Monotherapy%20in%20an%20Advanced%20Colorectal%20Cancer%20Patient&rft.jtitle=JNCI%20:%20Journal%20of%20the%20National%20Cancer%20Institute&rft.au=Tonini,%20Giuseppe&rft.date=2005-04-20&rft.volume=97&rft.issue=8&rft.spage=606&rft.epage=607&rft.pages=606-607&rft.issn=0027-8874&rft.eissn=1460-2105&rft.coden=JNCIEQ&rft_id=info:doi/10.1093/jnci/dji104&rft_dat=%3Cproquest_cross%3E862837311%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221025239&rft_id=info:pmid/15840884&rfr_iscdi=true |